These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21743236)

  • 1. Tumor marker and hemodialysis.
    Wiwanitkit V
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):805. PubMed ID: 21743236
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of tumor markers in chronic hemodialysis patients.
    Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour markers in chronic renal failure and haemodialysis patients.
    Eskiocak S; Dortok H; Alvur M; Cengiz K
    Nephrol Dial Transplant; 1995; 10(7):1256. PubMed ID: 7478140
    [No Abstract]   [Full Text] [Related]  

  • 4. Do cardiac troponins provide prognostic insight in hemodialysis patients?
    Choy JB; Armstrong PW; Ulan RA; Campbell PM; Gourishankar S; Prosser CI; Tymchak WJ
    Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients.
    Park CW; Shin YS; Kim CM; Lee SY; Yu SE; Kim SY; Choi EJ; Chang YS; Bang BK
    Am J Kidney Dis; 2002 Dec; 40(6):1230-9. PubMed ID: 12460042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: "cutoff" point and clinical applicability.
    Tsirpanlis G; Alevyzaki F; Triantafyllis G; Chatzipanagiotou S; Nicolaou C
    Am J Kidney Dis; 2005 Aug; 46(2):368; author reply 369. PubMed ID: 16112061
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y; Yue Z; Xialian X; Zhibin Y
    Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Egg on the table.
    Kazama JJ; Kaneko Y
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):14-5. PubMed ID: 19129315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of tumor markers in patients on chronic hemodialysis].
    Kuno T; Kaizu K
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():391-4. PubMed ID: 15250332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C
    Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of troponin T in patients with advanced chronic kidney failure. Clinical course after beginning hemodialysis].
    Fernández-Reyes MJ; Heras M; Sánchez R; Mon C
    Nefrologia; 2005; 25(5):574-5. PubMed ID: 16392311
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
    J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratio.
    Jacobs LH; Mingels AM; Wodzig WK; van Dieijen-Visser MP; Kooman JP
    Am J Clin Pathol; 2010 Sep; 134(3):516-7; author reply 517. PubMed ID: 20716809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid content of plasma in patients with chronic renal failure during hemodialysis treatment].
    Dembitskiĭ VM; Malyĭ VN
    Urol Nefrol (Mosk); 1984; (3):57-9. PubMed ID: 6740820
    [No Abstract]   [Full Text] [Related]  

  • 19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystopia of using (estimates of) glomerular filtration rate as a trigger for initiating dialysis.
    Adam WR
    Nephrology (Carlton); 2011 May; 16(4):381-2. PubMed ID: 21518117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.